Cargando…

Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma

BACKGROUND: Copper is an indispensably mineral element involved in various metabolic processes and functions in the active sites of many metalloproteins. Copper dysregulation is associated with cancers such as osteosarcoma (OS), the most common primary bone malignancy with invasiveness and metastasi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Binfeng, Liu, Zhongyue, Feng, Chengyao, Li, Chenbei, Zhang, Haixia, Li, Zhihong, Tu, Chao, He, Shasha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606239/ https://www.ncbi.nlm.nih.gov/pubmed/36313774 http://dx.doi.org/10.3389/fendo.2022.987942

Ejemplares similares

Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma
por: Liu, Binfeng, et al.
Publicado: (2022)

A novel necroptosis-related lncRNAs signature effectively predicts the prognosis for osteosarcoma and is associated with immunity
por: Liu, Binfeng, et al.
Publicado: (2022)

Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma
por: Liu, Zhongyue, et al.
Publicado: (2022)

A Necroptosis-Related lncRNA Signature Predicts Prognosis and Indicates the Immune Microenvironment in Soft Tissue Sarcomas
por: Liu, Binfeng, et al.
Publicado: (2022)

Integrative profiling analysis reveals prognostic significance, molecular characteristics, and tumor immunity of angiogenesis-related genes in soft tissue sarcoma
por: Liu, Binfeng, et al.
Publicado: (2023)

Integration analysis based on fatty acid metabolism robustly predicts prognosis, dissecting immunity microenvironment and aiding immunotherapy for soft tissue sarcoma
por: Liu, Binfeng, et al.
Publicado: (2023)

Integrative analysis of TROAP with molecular features, carcinogenesis, and related immune and pharmacogenomic characteristics in soft tissue sarcoma
por: Tu, Chao, et al.
Publicado: (2023)

A bibliometric and visualization analysis of glucocorticoid-induced osteoporosis research from 2012 to 2021
por: Jiang, Buchan, et al.
Publicado: (2022)

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
por: Zhong, Like, et al.
Publicado: (2023)

Construction of a cuproptosis‐related lncRNA signature for predicting prognosis and immune landscape in osteosarcoma patients
por: Ni, Shumin, et al.
Publicado: (2022)

A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
por: Yang, Mingyi, et al.
Publicado: (2022)

Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia
por: Zhu, Yidong, et al.
Publicado: (2023)

A four-lncRNA risk signature for prognostic prediction of osteosarcoma
por: Liu, Huanlong, et al.
Publicado: (2023)

A Novel Glutamine Metabolism-Related Gene Signature in Prognostic Prediction of Osteosarcoma
por: Wan, Lu, et al.
Publicado: (2022)

Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1
por: Shen, Junlin, et al.
Publicado: (2023)

Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma
por: Chen, Yuqiao, et al.
Publicado: (2022)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for acute myeloid leukemia
por: Li, Pian, et al.
Publicado: (2022)

Identification and validation of cuproptosis-related LncRNA signatures as a novel prognostic model for head and neck squamous cell cancer
por: Liu, Xiajing, et al.
Publicado: (2022)

A novel prognostic signature based on cuproptosis-related lncRNA mining in colorectal cancer
por: Hou, Dong, et al.
Publicado: (2022)

Construction of a Prognostic Model Based on Cuproptosis-Related lncRNA Signatures in Pancreatic Cancer
por: Jiang, Wenkai, et al.
Publicado: (2022)

Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma
por: Mai, Shijie, et al.
Publicado: (2022)

A novel cuproptosis-related prognostic lncRNA signature for predicting immune and drug therapy response in hepatocellular carcinoma
por: Chen, Shujia, et al.
Publicado: (2022)

Construction of lncRNA prognostic model related to cuproptosis in esophageal carcinoma
por: Zhang, Liming, et al.
Publicado: (2023)

MTHFR Polymorphism Is Associated With Severe Methotrexate-Induced Toxicity in Osteosarcoma Treatment
por: Zhang, Wenchao, et al.
Publicado: (2021)

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
por: Xu, Yifan, et al.
Publicado: (2022)

Cuproptosis-Related lncRNA Gene Signature Establishes a Prognostic Model of Gastric Adenocarcinoma and Evaluate the Effect of Antineoplastic Drugs
por: Tu, Hengjia, et al.
Publicado: (2022)

A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma
por: Wen, Jun, et al.
Publicado: (2023)

Radiosensitization-Related Cuproptosis LncRNA Signature in Non-Small Cell Lung Cancer
por: Xu, Qiushi, et al.
Publicado: (2022)

Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer
por: Pang, Lin, et al.
Publicado: (2023)

The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma
por: Li, Yao jun, et al.
Publicado: (2022)

A Noval Established Cuproptosis-Associated LncRNA Signature for Prognosis Prediction in Primary Hepatic Carcinoma
por: Luo, Lan, et al.
Publicado: (2022)

Identification and validation of a novel cuproptosis-related lncRNA signature for predicting colorectal cancer patients’ survival
por: Liu, Feng, et al.
Publicado: (2023)

Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC
por: Wang, Yu, et al.
Publicado: (2023)

Development and Evaluation of a Novel Cuproptosis-Related lncRNA Signature for Gastric Cancer Prognosis
por: Yin, Chunlin, et al.
Publicado: (2023)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
por: Zhang, Pengpeng, et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature to predict prognosis and immune microenvironment of colon adenocarcinoma
por: Li, Dongming, et al.
Publicado: (2023)

A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
por: Yu, Sheng, et al.
Publicado: (2023)

A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma
por: Xin, Sheng, et al.
Publicado: (2022)

A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma
por: Wu, Jingyi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b5luehg1kl1ngagb6lc2vr09v0